Banque Transatlantique's Megacap Concentration Play: $4.13B Portfolio Tilts Toward AI Giants

Marcus Chen

The Paris-based private bank's $4.13B portfolio reveals a concentrated bet on AI infrastructure leaders, with Microsoft and NVIDIA representing nearly one-quarter of assets.

Banque Transatlantique's Megacap Concentration Play: $4.13B Portfolio Tilts Toward AI Giants

Banque Transatlantique SA, the Paris-based private bank managing $4.13 billion in assets, has positioned itself as a concentrated megacap investor in Q4 2025. With 278 holdings and a WhaleScore of 82.75, the fund's portfolio reveals a deliberate tilt toward artificial intelligence and cloud infrastructure leaders—a strategic bet on the secular tech boom.

Portfolio Concentration: A Megacap Thesis

The fund's top 10 holdings account for 66.4% of total AUM, with the top 5 representing 46.4%. This concentration is not accidental. Banque Transatlantique's largest position is Microsoft (MSFT) at $519 million (12.6%), followed by NVIDIA (NVDA) at $492.5 million (11.9%). Together, these two AI infrastructure plays represent nearly one-quarter of the portfolio.

The third-largest holding, Amazon (AMZN), adds another $372.8 million (9.0%), rounding out a top-3 concentration of 33.5%. This trio—Microsoft, NVIDIA, and Amazon—forms the backbone of the fund's exposure to cloud computing, AI chips, and enterprise software.

The AI Infrastructure Narrative

Beyond the top 3, the portfolio reinforces this thesis. Apple (AAPL, 6.5%), Google (GOOG + GOOGL combined 11.1%), and Visa (V, 4.5%) complete the top-6 megacap cluster. Notably, NVIDIA's 11.9% weight reflects the fund's conviction in semiconductor demand driven by AI training and inference workloads.

Mid-tier holdings like Palo Alto Networks (PANW, 1.5%) and Synopsys (SNPS, 1.1%) suggest exposure to AI-adjacent cybersecurity and chip design tools. This is a portfolio built for the AI era, not a diversified index tracker.

Retail & Healthcare Ballast

Banque Transatlantique has also allocated to defensive, cash-generative businesses. Costco (COST, 4.4%), Walmart (WMT, 3.5%), and Home Depot (HD, 1.3%) provide consumer staples exposure. In healthcare, Boston Scientific (BSX, 2.8%), Intuitive Surgical (ISRG, 2.1%), and Eli Lilly (LLY, 1.8%) round out the portfolio with medical device and pharma exposure.

This mix suggests a "barbell" strategy: concentrated megacap tech bets paired with stable, dividend-paying consumer and healthcare names.

AUM Volatility & Recent Rebound

The fund's AUM history reveals significant volatility over the past five quarters:

  • 2024 Q4: $3.93B (290 holdings)
  • 2025 Q1: $1.51B (581 holdings) — sharp decline
  • 2025 Q2: $1.40B (123 holdings) — continued pressure
  • 2025 Q3: $1.73B (133 holdings) — stabilization
  • 2025 Q4: $4.13B (278 holdings) — strong rebound

The Q4 rebound to $4.13B suggests either significant new capital inflows or a sharp recovery in the value of existing megacap holdings. The reduction in holdings count from 290 to 278 indicates portfolio consolidation—fewer, larger positions.

Implications for Retail Investors

Banque Transatlantique's portfolio offers a clear signal: institutional capital is rotating toward AI infrastructure and megacap tech. The fund's 82.75 WhaleScore reflects this conviction. For retail investors tracking Banque Transatlantique's moves, the message is straightforward: megacap tech, especially AI-adjacent names like MSFT and NVDA, remain the dominant institutional bet heading into 2026.

The fund's willingness to concentrate 66% of assets in just 10 holdings—and 33.5% in just 3—suggests confidence in the durability of the AI infrastructure cycle. Whether this concentration proves prescient or risky will depend on the pace of AI adoption and the competitive dynamics among these megacap players.

Explore all research